Literature DB >> 24556591

18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.

Andrew G Horti1, Yongjun Gao, Hiroto Kuwabara, Yuchuan Wang, Sofya Abazyan, Robert P Yasuda, Thao Tran, Yingxian Xiao, Niaz Sahibzada, Daniel P Holt, Kenneth J Kellar, Mikhail V Pletnikov, Martin G Pomper, Dean F Wong, Robert F Dannals.   

Abstract

UNLABELLED: The α7-nicotinic cholinergic receptor (α7-nAChR) is a key mediator of brain communication and has been implicated in a wide variety of central nervous system disorders. None of the currently available PET radioligands for α7-nAChR are suitable for quantitative PET imaging, mostly because of insufficient specific binding. The goal of this study was to evaluate the potential of (18)F-ASEM ((18)F-JHU82132) as an α7-nAChR radioligand for PET.
METHODS: The inhibition binding assay and receptor functional properties of ASEM were assessed in vitro. The brain regional distribution of (18)F-ASEM in baseline and blockade were evaluated in DISC1 mice (dissection) and baboons (PET).
RESULTS: ASEM is an antagonist for the α7-nAChR with high binding affinity (Ki = 0.3 nM). (18)F-ASEM readily entered the baboon brain and specifically labeled α7-nAChR. The in vivo specific binding of (18)F-ASEM in the brain regions enriched with α7-nAChRs was 80%-90%. SSR180711, an α7-nAChR-selective partial agonist, blocked (18)F-ASEM binding in the baboon brain in a dose-dependent manner, suggesting that the binding of (18)F-ASEM was mediated by α7-nAChRs and the radioligand was suitable for drug evaluation studies. In the baboon baseline studies, the brain regional volume of distribution (VT) values for (18)F-ASEM were 23 (thalamus), 22 (insula), 18 (hippocampus), and 14 (cerebellum), whereas in the binding selectivity (blockade) scan, all regional VT values were reduced to less than 4. The range of regional binding potential values in the baboon brain was from 3.9 to 6.6. In vivo cerebral binding of (18)F-ASEM and α7-nAChR expression in mutant DISC1 mice, a rodent model of schizophrenia, was significantly lower than in control animals, which is in agreement with previous postmortem human data.
CONCLUSION: (18)F-ASEM holds promise as a radiotracer with suitable imaging properties for quantification of α7-nAChR in the human brain.

Entities:  

Keywords:  18F-ASEM; PET; baboon; nicotine; α7-nAChR

Mesh:

Substances:

Year:  2014        PMID: 24556591      PMCID: PMC4112566          DOI: 10.2967/jnumed.113.132068

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

1.  SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore.

Authors:  Michael R Schrimpf; Kevin B Sippy; Clark A Briggs; David J Anderson; Tao Li; Jianguo Ji; Jennifer M Frost; Carol S Surowy; William H Bunnelle; Murali Gopalakrishnan; Michael D Meyer
Journal:  Bioorg Med Chem Lett       Date:  2012-01-08       Impact factor: 2.823

2.  Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.

Authors:  I Aubert; D M Araujo; D Cécyre; Y Robitaille; S Gauthier; R Quirion
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

3.  Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.

Authors:  Andrew G Horti; Hayden T Ravert; Yongjun Gao; Daniel P Holt; William H Bunnelle; Michael R Schrimpf; Tao Li; Jianguo Ji; Heather Valentine; Ursula Scheffel; Hiroto Kuwabara; Dean F Wong; Robert F Dannals
Journal:  Nucl Med Biol       Date:  2013-01-05       Impact factor: 2.408

4.  Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.

Authors:  Yongjun Gao; Kenneth J Kellar; Robert P Yasuda; Thao Tran; Yingxian Xiao; Robert F Dannals; Andrew G Horti
Journal:  J Med Chem       Date:  2013-09-19       Impact factor: 7.446

5.  5-(5-(6-[(11)C]methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)pyridin-2-yl)-1H-indole as a potential PET radioligand for imaging cerebral α7-nAChR in mice.

Authors:  Yongjun Gao; Hayden T Ravert; Heather Valentine; Ursula Scheffel; Paige Finley; Dean F Wong; Robert F Dannals; Andrew G Horti
Journal:  Bioorg Med Chem       Date:  2012-05-04       Impact factor: 3.641

6.  [³H]Chiba-1001(methyl-SSR180711) has low in vitro binding affinity and poor in vivo selectivity to nicotinic alpha-7 receptor in rodent brain.

Authors:  Min Ding; Smita Ghanekar; Charles S Elmore; John R Zysk; Jennifer L Werkheiser; Chi-Ming Lee; Jianwei Liu; Vijay Chhajlani; Donna L Maier
Journal:  Synapse       Date:  2011-12-29       Impact factor: 2.562

7.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

Review 8.  Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

Authors:  Daniel S Auld; Tom J Kornecook; Stéphane Bastianetto; Rémi Quirion
Journal:  Prog Neurobiol       Date:  2002-10       Impact factor: 11.685

9.  Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.

Authors:  Zhi-Yan Han; Michele Zoli; Ana Cardona; Jean-Pierre Bourgeois; Jean-Pierre Changeux; Nicolas Le Novère
Journal:  J Comp Neurol       Date:  2003-06-16       Impact factor: 3.215

10.  Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.

Authors:  Jennifer M Kulak; Jay S Schneider
Journal:  Brain Res       Date:  2004-03-05       Impact factor: 3.252

View more
  27 in total

1.  Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.

Authors:  Dean F Wong; Hiroto Kuwabara; Martin Pomper; Daniel P Holt; James R Brasic; Noble George; Boris Frolov; William Willis; Yongjun Gao; Heather Valentine; Ayon Nandi; Lorena Gapasin; Robert F Dannals; Andrew G Horti
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

2.  [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.

Authors:  Yongjun Gao; Ronnie C Mease; Thao T Olson; Kenneth J Kellar; Robert F Dannals; Martin G Pomper; Andrew G Horti
Journal:  Nucl Med Biol       Date:  2014-12-20       Impact factor: 2.408

Review 3.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

4.  PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.

Authors:  Ansel T Hillmer; Songye Li; Ming-Qiang Zheng; Matthias Scheunemann; Shu-Fei Lin; Nabeel Nabulsi; Daniel Holden; Richard Pracitto; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Irina Esterlis; Kelly P Cosgrove; Peter Brust; Richard E Carson; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-24       Impact factor: 9.236

Review 5.  Opportunities in precision psychiatry using PET neuroimaging in psychosis.

Authors:  Jennifer M Coughlin; Andrew G Horti; Martin G Pomper
Journal:  Neurobiol Dis       Date:  2019-03-20       Impact factor: 5.996

6.  Ultrapotent chemogenetics for research and potential clinical applications.

Authors:  Christopher J Magnus; Peter H Lee; Jordi Bonaventura; Roland Zemla; Juan L Gomez; Melissa H Ramirez; Xing Hu; Adriana Galvan; Jayeeta Basu; Michael Michaelides; Scott M Sternson
Journal:  Science       Date:  2019-03-14       Impact factor: 47.728

Review 7.  Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors.

Authors:  Alina Kassenbrock; Neil Vasdev; Steven H Liang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 8.  Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.

Authors:  Andrew G Horti
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

9.  The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM.

Authors:  Jennifer M Coughlin; Yong Du; Hailey B Rosenthal; Stephanie Slania; Soo Min Koo; Andrew Park; Ghedem Solomon; Melin Vranesic; Inga Antonsdottir; Caroline L Speck; Kelly Rootes-Murdy; Alexandria Lerner; Steven P Rowe; Yuchuan Wang; Wojciech G Lesniak; Il Minn; Arnold Bakker; Gwenn S Smith; Robert F Dannals; Hiroto Kuwabara; Andrew Horti; Dean F Wong; Martin G Pomper
Journal:  Neuroimage       Date:  2017-10-07       Impact factor: 6.556

10.  PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.

Authors:  Ansel T Hillmer; Ming-Qiang Zheng; Songye Li; Matthias Scheunemann; Shu-fei Lin; Daniel Holden; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Richard E Carson; Peter Brust; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-12       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.